Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals REACH PRE-REGISTRATION ENDS TODAY: ECHA Opens Back-up System as Applications Top 2 MillionEvonik Sells U.K. Site to ManagementArkema Plans Further Restructuring of its Vinyls BusinessEvonik Rides the Economic Storm with Capacity Increases for Isobutene and MethionineSolvay Signs European Sustainability Charter Related Stories Mylan Completes Acquisition of Merck’s Generics BusinessWacker Adds to Biologics Capacity in GermanyWeylChem Hunts for ‘Sizable’ Deals to Further Increase SalesSaltigo Opens cGMP Plant; Eyes Accelerated GrowthGermany Joins U.S. in Recall of Contaminated Heparin

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

August 25, 2008

DSM Biologics to Produce Antibody for MorphoSys

Deepti Ramesh

DSM Biologics, a unit of DSM, says it has signed a biopharmaceutical manufacturing agreement with biotech firm MorphoSys (Martinsried, Germany). The deal calls for DSM to develop and manufacture MOR202, a fully human antibody for the treatment of multiple...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers